Postirradiation malignant fibrous histiocytoma

Area of Science:

• Oncology
• Radiation Oncology
• Pathology

Background:

• External radiation therapy is a common treatment modality for various cancers.
• Understanding the long-term side effects of radiation is crucial for patient management.
• Malignant fibrous histiocytoma (MFH) is a soft tissue sarcoma with complex cellular origins.

Observation:

• Three patients received successful postoperative external radiation therapy for different malignancies: ovarian carcinoma, endometrial adenocarcinoma, and bilateral retinoblastoma.
• Years after treatment, these patients developed malignant fibrous histiocytoma (MFH).
• The MFH in all cases arose within the previously irradiated field.

Findings:

• This case series suggests a potential link between external radiation therapy and the development of MFH.
• Malignant fibrous histiocytoma is characterized by its dual fibroblastic and histiocytic differentiation.
• The pleomorphic histologic appearance of MFH contributes to its diagnostic complexity.

Implications:

• Radiation oncologists and pathologists should be aware of the potential for secondary MFH development in patients treated with external beam radiation.
• Further research is warranted to elucidate the mechanisms underlying radiation-induced MFH.
• Long-term surveillance may be considered for patients treated with radiation for these specific conditions.